‹ Screener

PEPSICO INC

PEP · Beverages · 1.37B shares · -0%/yr ↓ buyback · EDGAR filings ↗
Net buyback after stock comp: $620M (gross $1.0B, SBC $380M)

Reference price $164.46 · est. market cap ~$224.8B — last insider sale, 2026-03-04 (estimated from the dated SEC Form 4 price × shares outstanding — not a live quote)

Grade

A85

Dominant global beverage and convenient-food franchise with iconic brands, pricing power, and exceptional returns.

Strengths

Risks

Notable findings

Quarterly revenue

2023-03-25 · $17.8B2024-03-23 · $18.2B2025-03-22 · $17.9B2026-03-21 · $19.4B

Last 4 quarters · from SEC filings.

Key metrics

Gross margin
54.1%
Operating margin
12.2%
Net margin
8.8%
Return on equity
40.4%
Return on assets
7.7%
ROIC
13.1%
Revenue growth (QoQ)
8.5%
Net-income growth
-14.0%
Debt / equity
2.4×
Net debt / EBITDA
2.7×
Interest coverage
10.3×
Current ratio
0.9×
EBITDA
$14.9B
Tangible book value
$990M
Cash & investments
$9.5B
Stock comp / revenue
0.3%

Insider transactions · last 18 months

DateInsiderTypeSharesPrice
2026-06-01VASELLA DANIELGrant424$141.52
2026-06-01Diamond Susan MGrant565$141.52
2026-06-01Bailey JenniferGrant424$141.52
2026-06-01Gibbs David WGrant71$141.52
2026-05-31VASELLA DANIELGrant1.5K
2026-05-31Bailey JenniferGrant125
2026-05-31Diamond Susan MGrant128
2026-05-06Gibbs David WGrant1.0K
2026-05-06Gibbs David WGrant534
2026-03-04Willemsen EugeneSell3.8K$164.46
2026-03-04Willemsen EugeneSell2.7K$164.44
2026-03-02Laguarta RamonSell28K$167.39
2026-03-02POHLAD ROBERT CGrant200$138.96
2026-03-02POHLAD ROBERT COther900K
2026-03-02POHLAD ROBERT COther900K
2026-03-01Schmitt BeckyDisposition1.1K
2026-03-01Schmitt BeckyTax withheld3.7K$169.05
2026-03-01Willemsen EugeneGrant13K
2026-03-01Willemsen EugeneGrant26K
2026-03-01Willemsen EugeneDisposition1.0K
2026-03-01Willemsen EugeneTax withheld3.9K$169.05
2026-03-01Popovici SilviuGrant14K
2026-03-01Popovici SilviuGrant27K
2026-03-01Popovici SilviuDisposition1.4K
2026-03-01Popovici SilviuTax withheld4.0K$169.05
2026-03-01Krishnan RamkumarGrant27K
2026-03-01Krishnan RamkumarGrant18K
2026-03-01Krishnan RamkumarTax withheld4.1K$169.05
2026-03-01Laguarta RamonGrant67K
2026-03-01Laguarta RamonGrant45K
2026-03-01Laguarta RamonDisposition6.9K
2026-03-01Laguarta RamonTax withheld25K$169.05
2026-03-01Krishnan RamkumarDisposition1.3K
2026-03-01Kanioura AthinaGrant27K
2026-03-01Kanioura AthinaGrant18K
2026-03-01Kanioura AthinaDisposition895
2026-03-01Kanioura AthinaTax withheld2.5K$169.05
2026-03-01Schmitt Stephen T.Grant18K
2026-03-01Schmitt Stephen T.Grant12K
2026-03-01Tammara Christine EGrant5.0K
2026-03-01Tammara Christine ETax withheld1.2K$169.05
2026-03-01Flavell DavidGrant12K
2026-03-01Flavell DavidGrant26K
2026-03-01Flavell DavidDisposition783
2026-03-01Flavell DavidTax withheld2.1K$169.05
2026-03-01Schmitt BeckyGrant11K
2026-03-01Schmitt BeckyGrant25K
2025-12-01Bailey JenniferGrant401$149.51
2025-12-01Lewis Dave JGrant401$149.51
2025-12-01Agbaje SegunGrant401$149.51
2025-12-01Diamond Susan MGrant535$149.51
2025-12-01VASELLA DANIELGrant401$149.51
2025-11-10Schmitt Stephen T.Grant49K$142.25
2025-10-01POHLAD ROBERT CGrant1.4K$143.14
2025-10-01Bailey JenniferGrant1.4K$143.14
2025-10-01Lewis Dave JGrant1.4K$143.14
2025-10-01Agbaje SegunGrant1.4K$143.14
2025-10-01Diamond Susan MGrant1.4K$143.14
2025-10-01Walker DarrenGrant1.4K$143.14
2025-10-01VASELLA DANIELGrant1.4K$143.14
2025-10-01Page David CGrant1.4K$143.14
2025-10-01Conde CesarGrant1.4K$143.14
2025-10-01COOPER EDITH WGrant1.4K$143.14
2025-10-01Gass MichelleGrant1.4K$143.14
2025-10-01COOK IAN MGrant1.4K$143.14
2025-10-01Weisser AlbertoGrant1.4K$143.14
2025-10-01DUBLON DINAGrant1.4K$143.14
2025-09-30Agbaje SegunGrant231
2025-09-30Gass MichelleGrant366
2025-09-30COOPER EDITH WGrant233
2025-09-30Conde CesarGrant607
2025-09-30Lewis Dave JGrant163
2025-09-30Page David CGrant723
2025-09-30COOK IAN MGrant1.6K
2025-09-30VASELLA DANIELGrant1.5K
2025-09-30Weisser AlbertoGrant1.1K
2025-09-30Walker DarrenGrant558
2025-09-30DUBLON DINAGrant1.7K
2025-09-30Diamond Susan MGrant95
2025-09-30POHLAD ROBERT CGrant694
2025-09-30Bailey JenniferGrant95
2025-06-01Lewis Dave JGrant458$130.91
2025-06-01Agbaje SegunGrant458$130.91
2025-06-01VASELLA DANIELGrant458$130.91
2025-06-01Diamond Susan MGrant458$130.91
2025-06-01Bailey JenniferGrant458$130.91
2025-06-01Schmitt BeckyTax withheld1.3K$132.00
2025-05-31Diamond Susan MGrant73
2025-05-31Bailey JenniferGrant73
2025-05-31Lewis Dave JGrant132
2025-05-31Agbaje SegunGrant190
2025-05-31VASELLA DANIELGrant1.3K
2025-03-04Gallagher Marie T.Sell25K$159.55
2025-03-04Willemsen EugeneGift7.6K
2025-03-04Willemsen EugeneGift7.6K
2025-03-03Krishnan RamkumarSell9.7K$150.91
2025-03-03Krishnan RamkumarSell225$153.51
2025-03-03Williams Steven CSell18K$150.89
2025-03-03Flavell DavidSell6.9K$150.90
2025-03-03Laguarta RamonSell50K$154.90
2025-03-03Willemsen EugeneSell10K$154.33
2025-03-01Krishnan RamkumarTax withheld11K$153.72
2025-03-01Schmitt BeckyGrant12K
2025-03-01Laguarta RamonGrant75K
2025-03-01Laguarta RamonGrant58K
2025-03-01Laguarta RamonTax withheld55K$153.72
2025-03-01Popovici SilviuGrant13K
2025-03-01Santilli PaulaGrant11K
2025-03-01Santilli PaulaGrant9.1K
2025-03-01Santilli PaulaTax withheld6.4K$153.72
2025-03-01Gallagher Marie T.Tax withheld3.1K$153.72
2025-03-01Willemsen EugeneGrant13K
2025-03-01Willemsen EugeneGrant7.6K
2025-03-01Willemsen EugeneTax withheld7.6K$153.72
2025-03-01Popovici SilviuGrant16K
2025-03-01Flavell DavidGrant12K
2025-03-01Williams Steven CTax withheld10K$153.72
2025-03-01Williams Steven CGrant14K
2025-03-01Ferdinando RachelGrant8.9K
2025-03-01Williams Steven CGrant25K
2025-03-01Ferdinando RachelTax withheld2.7K$153.72
2025-03-01Flavell DavidTax withheld5.2K$153.72
2025-03-01Caulfield James T.Grant14K
2025-03-01Krishnan RamkumarGrant17K
2025-03-01Krishnan RamkumarGrant12K
2025-03-01Popovici SilviuTax withheld9.6K$153.72
2025-03-01Flavell DavidGrant6.1K
2025-02-27Santilli PaulaSell7.8K$151.90
2025-02-27Santilli PaulaOption exercise7.8K$98.75

All non-derivative Form 4 activity (SEC), newest first.

Clinical trials

TrialTitlePhaseStatusPrimary completion
NCT07563855 ↗An Open Label Direct-to-Consumer Study Assessing the Impact of Health and Wellness Products on GI Health and Related Health Outcomes
Health, Wellness
NARecruiting2026-07-01
NCT03911427 ↗Oat and Cholesterol
Elevated LDL Cholesterol
NACompleted2020-02-20
NCT02020798 ↗Glycemic Response Testing
Glycemic Response
NACompleted2014-02-01

Source: ClinicalTrials.gov (U.S. NIH) · active studies first.

Supply chain

Suppliers (5)

Named in the 10-K; linked when we track them.

Notable events (8-K)

DateItems
2026-05-22OtherExhibitsfiling ↗
2026-05-08Shareholder votefiling ↗
2026-04-16ResultsExhibitsfiling ↗
2026-02-11OtherExhibitsfiling ↗
2026-02-03ResultsExhibitsfiling ↗
2025-12-15Exec/director changefiling ↗
2025-12-08Reg FDExhibitsfiling ↗
2025-10-09ResultsExec/director changeExhibitsfiling ↗

Recent filings

FormFiledPeriodAccession
8-K2026-05-222026-05-220001104659-26-065758 ↗
8-K2026-05-082026-05-060000077476-26-000024 ↗
8-K2026-04-162026-04-160000077476-26-000019 ↗
10-Q2026-04-162026-03-210000077476-26-000017 ↗
8-K2026-02-112026-02-110001104659-26-013379 ↗
10-K2026-02-032025-12-270000077476-26-000007 ↗
8-K2026-02-032026-02-030000077476-26-000009 ↗
8-K2025-12-152025-12-150000077476-25-000062 ↗
8-K2025-12-082025-12-080000077476-25-000059 ↗
8-K2025-10-092025-10-030000077476-25-000055 ↗
10-Q2025-10-092025-09-060000077476-25-000053 ↗
8-K2025-07-282025-07-280001104659-25-071182 ↗